GE HealthCare receives FDA clearance for AI-powered Pristina Recon DL mammography system
Curasight begins phase 1 trial of uTREAT in glioblastoma
Prestige Biopharma agrees Tuznue licence and supply deal for Latin America
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
Active Biotech to receive US patent for tasquinimod formulation
AstraZeneca to invest USD2bn in major Maryland manufacturing expansion
Nuvalent's zidesamtinib NDA filing accepted by US FDA
Hemispherian secures US patent allowance expanding GLIX1 patent protection
AbbVie receives approval for EPKINLY, rituximab and lenalidomide combination
Genentech reports first oral SERD to improve invasive disease-free survival in early breast cancer
Biotheryx completes enrolment in ongoing Phase 1a trial of BTX-9341 for HR+/HER2- breast cancer